Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perlin

Showing results (761-770 of 986) with videos related to

Pageof 99
Sort By:
Medical Care|November 30, 2002
Organizational predictors of adherence to ambulatory care screening guidelinesThomas E Vaughn, Kimberly D McCoy, Bonnie J BootsMiller, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafunginFernando César Bizerra, Cristina Jimenez-Ortigosa, Ana Carolina R Souza, et al.
American Journal of Infection Control|July 4, 2012
Infection prevention practices in adult intensive care units in a large community hospital system after implementing strategies to reduce health care-associated, methicillin-resistant Staphylococcus aureus infectionsJulia Moody, Edward Septimus, Jason Hickok, et al.
Physics in Medicine and Biology|March 27, 2024
New semi-analytical method for fast transcranial ultrasonic field simulationC Angla, H Chouh, P Mondou, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen <i>Candida glabrata</i> reveals the niche-specific requirement for <i>FKS1</i> and <i>FKS2</i> during infection and gut colonizationAmir Arastehfar, Farnaz Daneshnia, Hrant Hovhannisyan, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Journal of the National Cancer Institute|March 1, 1977
Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigensJ H Dean, J L McCoy, G B Cannon, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2025
Expression of 1,3-β-glucan synthase subunits in <i>Candida glabrata</i> is regulated by the cell cycle and growth conditions and at both transcriptional and post-transcriptional levelsIrene Gonzalez-Jimenez, Mikhail V Keniya, Ariel A Aptekmann, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair PathwayAshutosh Singh, Kelley R Healey, Priyanka Yadav, et al.
International Journal of Molecular Sciences|November 23, 2017
Identification and Initial Characterization of the Effectors of an Anther Smut Fungus and Potential Host Target ProteinsVenkata S Kuppireddy, Vladimir N Uversky, Su San Toh, et al.
Pageof 99

Showing results (761-770 of 986) with videos related to

Sort By:
Pageof 99
Medical Care|November 30, 2002
Organizational predictors of adherence to ambulatory care screening guidelinesThomas E Vaughn, Kimberly D McCoy, Bonnie J BootsMiller, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2014
Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafunginFernando César Bizerra, Cristina Jimenez-Ortigosa, Ana Carolina R Souza, et al.
American Journal of Infection Control|July 4, 2012
Infection prevention practices in adult intensive care units in a large community hospital system after implementing strategies to reduce health care-associated, methicillin-resistant Staphylococcus aureus infectionsJulia Moody, Edward Septimus, Jason Hickok, et al.
Physics in Medicine and Biology|March 27, 2024
New semi-analytical method for fast transcranial ultrasonic field simulationC Angla, H Chouh, P Mondou, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen <i>Candida glabrata</i> reveals the niche-specific requirement for <i>FKS1</i> and <i>FKS2</i> during infection and gut colonizationAmir Arastehfar, Farnaz Daneshnia, Hrant Hovhannisyan, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Journal of the National Cancer Institute|March 1, 1977
Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigensJ H Dean, J L McCoy, G B Cannon, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2025
Expression of 1,3-β-glucan synthase subunits in <i>Candida glabrata</i> is regulated by the cell cycle and growth conditions and at both transcriptional and post-transcriptional levelsIrene Gonzalez-Jimenez, Mikhail V Keniya, Ariel A Aptekmann, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair PathwayAshutosh Singh, Kelley R Healey, Priyanka Yadav, et al.
International Journal of Molecular Sciences|November 23, 2017
Identification and Initial Characterization of the Effectors of an Anther Smut Fungus and Potential Host Target ProteinsVenkata S Kuppireddy, Vladimir N Uversky, Su San Toh, et al.
Pageof 99